Crisaborole, sold under the brand name Eucrisa among others, is a nonsteroidal topical medication used for the treatment of mild-to-moderate atopic dermatitis (eczema) in adults and children. The most common side effects are reactions at the application site (including burning or stinging). Crisaborole is a phosphodiesterase 4 (PDE-4) inhibitor, although its specific mechanism of action in atopic dermatitis is not known.
Property | Value |
---|---|
dbo:abstract |
|
dbo:alternativeName |
|
dbo:casNumber |
|
dbo:chEBI |
|
dbo:chEMBL |
|
dbo:drugbank |
|
dbo:fdaUniiCode |
|
dbo:kegg |
|
dbo:medlinePlus |
|
dbo:pubchem |
|
dbo:thumbnail | |
dbo:wikiPageExternalLink | |
dbo:wikiPageID |
|
dbo:wikiPageLength |
|
dbo:wikiPageRevisionID |
|
dbo:wikiPageWikiLink |
|
dbp:atcPrefix |
|
dbp:atcSuffix |
|
dbp:b |
|
dbp:c |
|
dbp:casNumber |
|
dbp:chebi |
|
dbp:chembl |
|
dbp:chemspiderid |
|
dbp:dailymedid |
|
dbp:drugbank |
|
dbp:h |
|
dbp:iupacName |
|
dbp:kegg |
|
dbp:legalCa |
|
dbp:legalEu |
|
dbp:legalStatus |
|
dbp:legalUs |
|
dbp:licenceEu |
|
dbp:medlineplus |
|
dbp:n |
|
dbp:o |
|
dbp:pregnancyAu |
|
dbp:pregnancyUs |
|
dbp:pubchem |
|
dbp:routesOfAdministration |
|
dbp:smiles |
|
dbp:stdinchi |
|
dbp:stdinchikey |
|
dbp:synonyms |
|
dbp:tradename |
|
dbp:unii |
|
dbp:wikiPageUsesTemplate | |
dcterms:subject | |
rdf:type | |
rdfs:comment |
|
rdfs:label |
|
owl:sameAs | |
prov:wasDerivedFrom | |
foaf:depiction | |
foaf:isPrimaryTopicOf | |
is dbo:wikiPageRedirects of | |
is dbo:wikiPageWikiLink of |
|
is foaf:primaryTopic of |